CompoAtlas

EU YAN SANG LOK MEI PA PLUS PILLS

EU YAN SANG LOK MEI PA PLUS PILLS : Product registered in Malaysia. This registration does not constitute authorisation for sale in France or the European Union. It does not demonstrate the safety or efficacy of the product.

NPRA, Malaysian pharmaceutical products register, retrieved 27 October 2026.

Ministry of Health Malaysia / NPRA, Pharmaceutical Products, CC BY 4.0

CC BY 4.0

The foreign register category does not determine the regulatory category of the product in France.

French and European references for recognised ingredients

Unidentified ingredients are not assessed. The absence of a signal does not establish product compliance.

Published composition

Published ingredientPublished text and quantityIdentified nutrient or substance
Ginseng rubraGinseng rubra[83 mg,6 g]Not identified
Cordyceps sinensisCordyceps sinensis[77 mg,6 g]Not identified
Astragalus membranaceusAstragalus membranaceus[110 mg,6 g]Not identified
Codonopsis pilosulaCodonopsis pilosula[140 mg,6 g]Not identified
Morinda officinalisMorinda officinalis[110 mg,6 g]Not identified
Lycium barbarumLycium barbarum[170 mg,6 g]Not identified
Paeoniae albaPaeoniae alba[170 mg,6 g]Not identified
Poria cocosPoria cocos[140 mg,6 g]Not identified
Dioscorea oppositaDioscorea opposita[140 mg,6 g]Not identified
Polygala tenuifoliaPolygala tenuifolia[140 mg,6 g]Not identified
Ziziphus spinosaZiziphus spinosa[140 mg,6 g]Not identified
Atractylodes macrocephalaAtractylodes macrocephala[140 mg,6 g]Not identified
Paeonia suffruticosaPaeonia suffruticosa[110 mg,6 g]Not identified
Achyranthes bidentataAchyranthes bidentata[140 mg,6 g]Not identified
Cibotium barometzCibotium barometz[140 mg,6 g]Not identified
Nelumbo nuciferaNelumbo nucifera[170 mg,6 g]Not identified
Glycine maxGlycine max[740 mg,6 g]Not identified
Cervus nipponCervus nippon[140 mg,6 g]Not identified
MelMel[3000 mg,6 g]Not identified

The imported data provide no usable daily dosage. No daily dose is estimated and no comparison with dose limits is performed. A published quantity may refer to a preparation or an unspecified unit. Chinese names are retained without translation.

Product record

Registration number
MAL18076027T
Type
Natural product
Published status
PRODUCT APPROVED
Licence holder
EU YAN SANG (1959) SDN.BHD.
Manufacturer
WENG LI SDN. BHD.
Importer
NOT APPLICABLE
Registration period starting
2023-07-05
Published validity end
2028-07-05

Original register data

View published fields and their variants
Active ingredients
Ginseng rubra[83 mg,6 g],Cordyceps sinensis[77 mg,6 g],Astragalus membranaceus[110 mg,6 g],Codonopsis pilosula[140 mg,6 g],Morinda officinalis[110 mg,6 g],Lycium barbarum[170 mg,6 g],Paeoniae alba[170 mg,6 g],Poria cocos[140 mg,6 g],Dioscorea opposita[140 mg,6 g],Polygala tenuifolia[140 mg,6 g],Ziziphus spinosa[140 mg,6 g],Atractylodes macrocephala[140 mg,6 g],Paeonia suffruticosa[110 mg,6 g],Achyranthes bidentata[140 mg,6 g],Cibotium barometz[140 mg,6 g],Nelumbo nucifera[170 mg,6 g],Glycine max[740 mg,6 g],Cervus nippon[140 mg,6 g],Mel[3000 mg,6 g]
Valid until
2028-07-05
Registration date
2023-07-05
Published description
NATURAL PRODUCT
Licence holder
EU YAN SANG (1959) SDN.BHD.
Importer
NOT APPLICABLE
Producer
WENG LI SDN. BHD.
Published name
EU YAN SANG LOK MEI PA PLUS PILLS
Published reference
201712061152T
Registration number
MAL18076027T
Published status
PRODUCT APPROVED

Official source

View the official register, number MAL18076027T

Ministry of Health Malaysia / NPRA, Pharmaceutical Products, CC BY 4.0

CC BY 4.0

Official warnings (Health Canada)

Health Canada publishes warnings on these ingredients:

  • Astragalus membranaceus
    Read the warning, when it applies and the studies cited

    ASTRAGALUS - ASTRAGALUS MEMBRANACEUS

    Route of administration: Oral

    Cautions and warnings

    Condition of application: All products.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant or breastfeeding.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you have an autoimmune disorder (Brinker 2010; Upton 1999).

    Sources cited by Health Canada (2)
    • Brinker F. Herb Contraindications and Drug Interactions, 4th edition. Sandy (OR): Eclectic Medical Publications; 2010.
    • Upton R, editor. American Herbal Pharmacopoeia and Therapeutic Compendium: Astragalus Root. Santa Cruz (CA): American Herbal Pharmacopoeia; 1999.

    Contraindications

    Condition of application: Traditional Chinese Medicine.

    Do not use if you have exterior excess, stagnation, yin deficiency or excess heat (Bensky et al. 2004; Chen and Chen 2004).

    Sources cited by Health Canada (2)
    • Bensky D, Clavey, Stöger E, Gamble A. Chinese Herbal Medicine: Materia Medica. 3rd edition. Seattle (WA): Eastland Press, Incorporated; 2004.
    • Chen JK, Chen TT. Chinese Medical Herbology and Pharmacology. Crampton L, editor. City of Industry (CA): Art of Medicine Press Inc.; 2004.

    Health Canada monograph dated 30 May 2025

  • Glycine max
    Read the warning, when it applies and the studies cited

They concern the ingredient, not this product or its dose. They do not replace medical advice.

The evidence date of this ingredient list is unknown.

Has the product changed? Photograph the packaging.

Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.

Cite this page: CompoAtlas, “EU YAN SANG LOK MEI PA PLUS PILLS”, https://compoatlas.com/en/supplements/malaysia/MAL18076027T-eu-yan-sang-lok-mei-pa-plus-pills, updated 27 October 2026.

Enter to analyse, Shift+Enter for a new line